2015
DOI: 10.4236/ajac.2015.62012
|View full text |Cite
|
Sign up to set email alerts
|

Fighting Poor Quality Medicines: Development, Transfer and Validation of Generic HPLC Methods for Analyzing Two WHO Recommended Antimalarial Tablets

Abstract: As serious but neglected public health problems, poor quality medicines, i.e. for antimalarial medicines, urged to be fought. One of the approaches is to consider the analytical chemistry and separative techniques. In this study, a generic liquid chromatographic method was firstly developed for the purpose of screening 8 antimalarial active ingredients, namely amodiaquine (AQ), piperaquine (PPQ), sulfalene (SL), pyrimethamine (PM), lumefantrine (LF), artesunate (AS), artemether (AM) and dihydroartemisinine (DH… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
6
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…Moreover, ion-pair reagents most often drastically increase the equilibration time of the chromatographic column, leading to a high consumption of mobile phases and long analysis times. In the literature, there are some publications about the simultaneous HPLC analysis of AL in formulations [22][23][24][25][26][27]. However, they have not been developed according to the green analytical chemistry principles.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, ion-pair reagents most often drastically increase the equilibration time of the chromatographic column, leading to a high consumption of mobile phases and long analysis times. In the literature, there are some publications about the simultaneous HPLC analysis of AL in formulations [22][23][24][25][26][27]. However, they have not been developed according to the green analytical chemistry principles.…”
Section: Introductionmentioning
confidence: 99%
“…Artemether/Lumefantrine in Tablet Formulations Reference to the USP, International and European pharmacopoeias allowable adjustments in chromatographic systems [13] [14] [15], our previously validated method for the analysis of artemether/lumefantrine in tablets forms [16] was adjusted in order to reduce the analysis time and increase the sample analysis throughput. The following solutions were prepared:…”
Section: Sample Solutions For Methods Adjustment For the Analysis Ofmentioning
confidence: 99%
“…Artemether/Lumefantrine in Tablet Formulations Our former analytical method for the analysis of artemether/lumefantrine in tablet formulations [16] was readjusted to improve the analysis time (run time), and sample treatment by increasing the capacity of methanol in dissolving lumefantrine. Hence, to improve the analysis time, we slightly increased the proportion of methanol in the mobile phase and the run time reduced; then, to increase the capacity of methanol in dissolving lumefantrine, we slightly increased the acidity power by using methanol acidified with phosphoric acid 0.2% (w/v) instead of 0.1% (w/v) previously used.…”
Section: Adjustment Of the Methods For Analysis Ofmentioning
confidence: 99%
See 1 more Smart Citation
“…However, this reagent may stick to the columns and may only be removed after extensive flushing procedures, consuming high volumes of mobile phase and time, which is contrary to green chemistry principles. In the literature, there are some publications about the simultaneous HPLC analysis of AS and AQ in formulations [21][22][23][24], but they have not been developed according to GAC criteria. Also, AQ peak appears asymmetrical except in one publication where an ion-pairing agent (octanesulfonate) was added to improve AQ peak shape [23].…”
mentioning
confidence: 99%